Rchr
J-GLOBAL ID:201201027867764282   Update date: Nov. 13, 2024

Umehara Takashi

ウメハラ タカシ | Umehara Takashi
Affiliation and department:
Job title: Senior Scientist
Homepage URL  (2): https://www.bdr.riken.jp/ja/research/labs/umehara-t/index.htmlhttps://www.bdr.riken.jp/en/research/labs/umehara-t/index.html
Research field  (3): Structural biochemistry ,  Molecular biology ,  Pharmaceuticals - health and biochemistry
Research keywords  (12): Drug Discovery ,  Synthetic Biology ,  Molecular Biology ,  Nucleosome ,  Histone ,  Epigenetics ,  Gene Expression ,  Chemical Biology ,  Chromatin ,  Structural Biology ,  Chromosome ,  Biochemistry
Research theme for competitive and other funds  (14):
  • 2024 - 2028 リシンアセチル化による後成遺伝情報の発現と継承の仕組みを理解する
  • 2021 - 2024 LSD阻害剤の創製:LSD1阻害剤の創薬展開およびLSD2機能解明の基盤構築
  • 2020 - 2024 がん細胞で頑強に維持される超アセチル化エピゲノムを操作する
  • 2021 - 2023 エピゲノムの修飾密度と分子内相互作用による転写バースト形成の再構成的理解
  • 2020 - 2022 人工細胞膜に封入した後成修飾クロマチン繊維の細胞内導入と遺伝子発現の定量的理解
Show all
Papers (103):
  • Yohsuke T. Fukai, Tomoya Kujirai, Masatoshi Wakamori, Setsuko Kanamura, Lisa Yamauchi, Somayeh Zeraati, Chiharu Tanegashima, Mitsutaka Kadota, Hitoshi Kurumizaka, Takashi Umehara, et al. Engineered acetylation patterns drive large-scale chromatin organizationin vitro. 2024
  • Keiko Shinjo, Takashi Umehara, Hideaki Niwa, Shin Sato, Keisuke Katsushima, Shinya Sato, Xingxing Wang, Yoshiteru Murofushi, Miho M. Suzuki, Hiroo Koyama, et al. Novel pharmacologic inhibition of lysine-specific demethylase 1 as a potential therapeutic for glioblastoma. Cancer Gene Therapy. 2024
  • Yosuke Nishigaya, Shohei Takase, Tatsunobu Sumiya, Tomohiro Sato, Hideaki Niwa, Shin Sato, Akiko Nakata, Seiji Matsuoka, Yuki Maemoto, Noriaki Hashimoto, et al. Structure-based development of novel substrate-type G9a inhibitors as epigenetic modulators for sickle cell disease treatment. Bioorganic & Medicinal Chemistry Letters. 2024. 110. 129856-129856
  • Shinsuke Ito, Takashi Umehara, Haruhiko Koseki. Polycomb-mediated histone modifications and gene regulation. Biochemical Society Transactions. 2024. 52. 1. 151-161
  • Akari Miwa, Masatoshi Wakamori, Tetsuro Ariyoshi, Yasushi Okada, Mikako Shirouzu, Takashi Umehara, Koki Kamiya. Efficiency of transcription and translation of cell-free protein synthesis systems in cell-sized lipid vesicles with changing lipid composition determined by fluorescence measurements. Scientific Reports. 2024. 14. 1. 2852-2852
more...
MISC (28):
more...
Patents (13):
Books (12):
  • がんゲノム医療時代の分子腫瘍学: エピジェネティクス (2) ヒストン修飾の異常
    病理と臨床 Vol. 40 臨時増刊号 pp. 26-30 2022
  • エピゲノム創薬によるターゲット探索とその開発・応用動向
    疾患原因遺伝子(技術情報協会)pp. 49-59 2022
  • Academic drug discovery by platforms of structure analysis and in silico design
    J. Clin. Exp. Med. 254(8) 566-570 2015
  • New frontiers of epigenetics researches in pharmaceutical sciences
    J. Pharm. Soc. Jpn. 135(1) 1-2 2015
  • Analysis of gene expression regulation through precise reconstitution of ‘epi-nucleosome’
    Seitai No Kagaku (Igaku Shoin Ltd.) 65(5) 462-463 2014
more...
Education (2):
  • 1994 - 1999 The University of Tokyo Graduate School of Pharmaceutical Sciences
  • 1990 - 1994 The University of Tokyo Faculty of Pharmaceutical Sciences
Professional career (1):
  • Ph.D. (The University of Tokyo)
Work history (8):
  • 2023 - 現在 RIKEN Senior Scientist
  • 2019 - 2023 RIKEN Team Leader
  • 2013 - 2019 RIKEN Unit Leader
  • 2007 - 2013 RIKEN Senior Scientist
  • 2005 - 2007 RIKEN Research Scientist
Show all
Committee career (2):
  • 2022 - 現在 Epigenomes Editorial Board Member
  • 2021 - 現在 ACS Bio & Med Chem Au Editorial Advisory Board Member
Awards (1):
  • 2011 - The Japanese Society for Epigenetics Young Investigator Award
Association Membership(s) (6):
JAPANESE SOCIETY FOR CHEMICAL BIOLOGY ,  PROTEIN SCIENCE SOCIETY OF JAPAN ,  THE JAPANESE SOCIETY FOR EPIGENETICS ,  THE PHARMACEUTICAL SOCIETY OF JAPAN ,  THE MOLECULAR BIOLOGY SOCIETY OF JAPAN ,  The Japanese Biochemical Society
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page